Holen Sie sich die Stockscreener-App
2.17
2.25%
-0.05
Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.99%
5.5901
|
5.3759 | 4.5238 | 3.7207 | 2.5208 |
| Operating Income/Loss |
3.99%
-5.5901
|
-5.3759 | -4.5238 | -3.7207 | -2.5208 |
| Nonoperating Income/Loss |
0.2679
|
- | - | 0.1288 | 0.0279 |
| Income/Loss From Continuing Operations Before Tax |
3.40%
-5.3222
|
-5.1473 | -4.3371 | -3.5919 | -2.4929 |
| Income Tax Expense/Benefit |
9.27%
0.00884
|
0.00809 | 0.00681 | 0.00635 | 0.00517 |
| Income/Loss From Continuing Operations After Tax |
3.41%
-5.3311
|
-5.1554 | -4.3439 | -3.5982 | -2.498 |
|
Net Income/Loss
|
3.41%
-5.3311
|
-5.1554 | -4.3439 | -3.5982 | -2.498 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
9.43%
-0.0721
|
-0.0659 | -0.0632 | - | - |
| Basic Average Shares |
1,484%
23.44
|
1.48 | 18.58 | 15.04 | 13.90 |
| Diluted Average Shares |
1,484%
23.44
|
1.48 | 18.58 | 15.04 | -0.5706 |
| Basic Earnings Per Share |
8.33%
-0.22
|
-0.24 | -0.23 | -0.24 | -0.18 |
| Diluted Earnings Per Share |
8.33%
-0.22
|
-0.24 | -0.23 | -0.24 | -0.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):